|
000
| 01383cam 2200325zi 4500 |
|---|
| 001 | 9.870025 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107163018 |
|---|
| 006 | m o d f |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 190315t20192019onc |o f00| 0 eng d |
|---|
| 020 | |a9780660300528 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aNR16-266/2019E-PDF |
|---|
| 245 | 00|aA549 expression system : |bfor producing adenoviral vectors - licensing opportunity L-10624. |
|---|
| 264 | 1|a[Ottawa] : |bNational Research Council Canada = Conseil national de recherches Canada, |c2019. |
|---|
| 264 | 4|c©2019 |
|---|
| 300 | |a1 online resource (2 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Système d’expression A549 pour la production de vecteurs adénoviraux (L-10624). |
|---|
| 500 | |aCaption title. |
|---|
| 650 | 0|aAdenoviruses. |
|---|
| 650 | 0|aGenetic vectors|xTherapeutic use. |
|---|
| 710 | 2 |aNational Research Council Canada, |eissuing body. |
|---|
| 775 | 08|tSystème d’expression A549 pour la production de vecteurs adénoviraux (L-10624).|w(CaOODSP)9.870030 |
|---|
| 776 | 0#|tA549 expression system to produce adenoviral vectors.|w(CaOODSP)9.870026 |
|---|
| 856 | 40|qPDF|s200 KB|uhttps://publications.gc.ca/collections/collection_2021/cnrc-nrc/NR16-266-2019-eng.pdf |
|---|